
|Articles|April 1, 2002
Legislators plan to take aim at 'inflated' drug prices
System based on average sales price would reduce overpayments, membersof Congress sayWashington-Convinced that physicians are somehow ripping off Medicareby overcharging for prescription drugs, members of Congress are workingto find a solution. The eventual result could be restrictions on drug charges,combined with improvements in reimbursement levels for some cognitive services.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
3
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5











